ArticleCytotherapy2024

Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment.

Ioulia Vogiatzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.